Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661021 · ClinicalTrials.gov registry record
Study of the Ability of a New Technique to Effectively Diagnose Movement Disorders
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 40
- Enrollment target
NCT03661021 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 40 participants.
The verdict
NCT03661021 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Sante Fe is an investigation of a new technique to distinguish between different types of movement disorders, specifically organic versus functional, by observing changes in involuntary movements in two different situations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2024-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03661021
The ClinicalTrials.gov registry entry for NCT03661021 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03661021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03661021 about?
NCT03661021 is a clinical study titled "Study of the Ability of a New Technique to Effectively Diagnose Movement Disorders". Sante Fe is an investigation of a new technique to distinguish between different types of movement disorders, specifically organic versus functional, by observing changes in involuntary movements in two different situations.
What is the current status of trial NCT03661021?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-07-18. Estimated completion is 2024-07-22.
Who is sponsoring clinical trial NCT03661021?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.